title: Rationale for using recombinant human erythropoietin to treat the anemia of prematurity.
authors.affiliation: Department of Pediatrics and Cardiovascular Research Institute, University of California, San Francisco.
authors.forename: R H
authors.initials: RH
authors.lastname: Phibbs
authors.forename: K
authors.initials: K
authors.lastname: Shannon
authors.forename: W C
authors.initials: WC
authors.lastname: Mentzer
mesh_terms: D000740:Anemia / Q000097:blood / Q000188:drug therapy* / Q000628:therapy; D001803:Blood Transfusion; D004921:Erythropoietin / Q000627:therapeutic use*; D006400:Hematocrit; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007234:Infant, Premature
chemical_list: D004921:Erythropoietin